Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Invested Capital (2022 - 2026)

Cingulate's (CINGW) quarterly Invested Capital came in at $28.5 million in Q2 2026, up 186.59% quarter-over-quarter from $10.0 million in Q4 2025.

Analysis

Cingulate (CINGW) Invested Capital (2022 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Invested Capital for 5 consecutive years, with $28.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Invested Capital changed N/A year-over-year to $28.5 million; the trailing twelve-month figure through Jun 2026 stood at $28.5 million (changed N/A YoY), and the FY2025 full-year result was $10.0 million, down 95.94% from the prior year.
  • Invested Capital improved to $28.5 million in Q2 2026 per CINGW's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $28.5 million in Q2 2026 and bottomed at -$1.8 million in Q4 2023.
  • Historically, Invested Capital has averaged $9.2 million across 5 years, with a median of $8.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 119.92% in 2023, then soared 801.89% in 2024.
  • Over 5 years, Invested Capital stood at $8.9 million in 2022, then plunged by 119.92% to -$1.8 million in 2023, then jumped by 801.89% to $12.4 million in 2024, then fell by 19.83% to $10.0 million in 2025, then jumped by 186.59% to $28.5 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods registered $28.5 million, $10.0 million, and $6.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 646.24 Bn 625.48 Bn 17.26 Bn 145.70 Bn
2 AbbVie 441.52 Bn 434.96 Bn 12.70 Bn 64.89 Bn
3 Merck 365.75 Bn 358.60 Bn 12.21 Bn 159.97 Bn
4 Novartis Ag 266.61 Bn 258.92 Bn 11.24 Bn 51.53 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn 148.69 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 106.05 Bn
7 Revolution Medicines 44.04 Bn 44.04 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 6.38 Bn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn -
10 Cingulate 100,214.03 100,214.03 - 28.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.53 Mn
Dec 31, 2025 9.96 Mn
Sep 30, 2025 6.66 Mn
Mar 31, 2025 10.98 Mn
Dec 31, 2024 12.42 Mn
Dec 31, 2023 -1.77 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2023 1.90 Mn
Mar 31, 2023 5.08 Mn
Dec 31, 2022 8.88 Mn
Sep 30, 2022 13.37 Mn